As more therapies move into the home, pharmaceutical companies are confronting a new challenge: ensuring patients have the confidence, support, and guidance needed to successfully start and stay on treatment. In a conversation on The Top Line, Adam Shain, Vice President and Head of Business Transformation and Growth and Government Affairs Lead at Noble, an Aptar Pharma company, argues that patient onboarding, device training, and engagement strategies can no longer operate in silos.
Drawing on years of experience in self-administration support, Shain discusses why patient insights should serve as the foundation for program design, how the rapid growth of self-injection therapies is reshaping patient expectations, and why the industry's focus is shifting beyond treatment initiation to long-term adherence. He also explores the opportunities and challenges presented by connected health technologies, including how pharmaceutical companies can turn expanding streams of patient data into actionable insights that improve outcomes across the care journey.